Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine in the menopause.

I Fettes1

  • 1University of Toronto, Sunnybrook and Women's College Health Sciences Centre, Ontario, Canada.

Neurology
|September 16, 1999
PubMed
Summary

Menopausal women experiencing migraine may find relief with hormone replacement therapy. Continuous combined estrogen and progesterone therapy is preferred to stabilize hormone levels and reduce migraine frequency and severity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menstrual migraine. Methods of prevention and control.

Postgraduate medicine·1997
Same author

Multifocal eosinophilic granuloma with a pituitary stalk lesion.

The Western journal of medicine·1985
Same author

Endorphin levels in headache syndromes.

Headache·1985
Same author

Plasma levels of immunoreactive beta-endorphin and adrenocorticotropic hormone during labor and delivery.

Obstetrics and gynecology·1984
Same author

Expression of cloned beta-endorphin gene sequences by Escherichia coli.

Nature·1980
Same author

Adrenoleukodystrophy: report of a familial case.

Clinical endocrinology·1979

Area of Science:

  • Neurology
  • Endocrinology
  • Women's Health

Background:

  • Migraine exacerbations are common in perimenopausal women due to fluctuating estrogen and progesterone.
  • Loss of regular hormone patterns during menopause can trigger or worsen migraine frequency and severity.

Purpose of the Study:

  • To evaluate the efficacy of hormone replacement therapy (HRT) in managing migraine in menopausal women.
  • To determine the optimal HRT regimen for women with a history of menstrual migraine.

Main Methods:

  • Review of existing literature on HRT and migraine management.
  • Analysis of hormone secretion patterns during perimenopause and menopause.
  • Comparison of continuous combined vs. cyclic HRT for migraine control.

Main Results:

  • Fluctuating estrogen levels during perimenopause can increase migraine frequency and severity.
  • Restoration and stabilization of estrogen levels may diminish migraine.
  • Continuous combined HRT (estrogen and progesterone) is recommended over cyclic HRT for migraine management.

Conclusions:

  • Continuous combined HRT is the preferred therapy for menopausal women with migraine.
  • Estrogen therapy alone may be used if the uterus has been removed.
  • Progesterone should be added for women with a uterus to stabilize hormone levels and manage migraine.

Related Experiment Videos